Trending...
- Billboard, Music Week, and DJ Times Charting Recording Artist, NOAH, Releases Groundbreaking Single "BABYMAKER"
- Mayor Wu and City of Boston Celebrate Immigrant Heritage Month
- Massachusetts: MCSW Announces Keynote Speakers for Historic 25th Anniversary Gala
~ 132 Terrace Street is now available for purchase at a price of $225,000. To qualify for this property, applicants must have an annual income equal to or less than $78,550 for one person and $89,750 for two persons. The unit is available on a first come, first serve basis. Those interested in applying must fill out an expression of interest form and meet the owner-occupancy requirements. Income and asset limitations are based on 80% Area Median Income Limits as defined by HUD. Persons with disabilities and those with limited English language proficiency are entitled to request a reasonable accommodation.
More on Boston Chron
More on Boston Chron
- We Decode Launches New Affiliate Program to Help Communities Improve Their Health
- Bahamas to Host the 2023 Caribbean Masters' Track and Field Championship Labor Day Weekend
- ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress
- Research Urges Standardization of FDA's Human Factors Engineering Practices Within the Medical Device Industry
- City of Boston Opens Applications for Nightlife Initiative for a Thriving Economy Committee
0 Comments
Latest on Boston Chron
- Congratulations to Olga Torres for 6th Consecutive Year of Chambers and Partners Recognition
- Boston: LinkedInsights: Abigail Milewski
- Smart Cities of the Future by Vine Strategy
- Tom Olen Memorial Fund Awards Scholarship to a Norwood High School Senior
- Electives named 'Corporate Learning Solution of the Year' by EdTech Breakthrough
- Syros to Present at Sidoti June 2023 Virtual Small-Cap Conference
- The Data Economics Company and Gordian Knot Strategies Highlight Deployment of Enkrateia Platform for More Strategic Investments in U.S. Forests
- Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma
- Strivve partners with innovative Reseda Group
- RevBio krijgt 2 miljoen dollar subsidie om de ontwikkeling van zijn nieuwe implantaatproduct voor de tandheelkundige hechting van botfragmenten te bevorderen
- Hanover Crossing Welcomes Twelve Tesla Superchargers
- RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product
- Timing is Key: Discover the Advantages of Selling Now, Backed by Experts
- Governor Healey Re-Nominates Dr. Charlene Bonner to Massachusetts Parole Board
- Life Sciences Workforce Initiative Launched for Boston Residents
- Spring is in bloom with our May partners!
- Get Ready for Fireworks in Sexy Red, White, and Blue Bustier Babydoll Lingerie
- Pacific Program Management Promotes Guy Faretra to National Director, Delivery Services
- Financial IT Launches Fintech Pathfinder: Showcasing the Most Promising Fintech Startups
- Wágner Resurfaces with Second Single "I Ran" After 30-Year Hiatus